Dialyzer and Dialysis Market size is estimated to reach USD 244.18 Billion by the end of 2036, growing at a CAGR of 6.07% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of dialyzer and dialysis was USD 113.6 Billion. The geriatric population is predicted to see significant growth throughout the forecast period due to the steady increase in this demographic worldwide and the increased likelihood of numerous ailments linked with aging, including kidney-related diseases. The percentage of people over 60 in the world will almost double from 12% to 22% between 2015 and 2050.
In addition to these, dialyzers play a crucial role in the medical field for people with renal disorders. Dialysis is mostly used by people whose kidneys are not functioning correctly to make the process easier. With the enrollment of their first participant, AWAK Technologies (AWAK) and Singapore General Hospital (SGH) initiated the pre-pivotal clinical trial in June 2023 to investigate the safety and effectiveness of an upgraded Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) machine. The US Food and Drug Administration (FDA) has designated the wearable, ultra-portable AWAK PD peritoneal dialysis (PD) system as a "Breakthrough Device Designation," enabling patients with end-stage kidney disease to get dialysis on the go.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
6.07% |
|
Base Year Market Size (2023) |
USD 113.6 Billion |
|
Forecast Year Market Size (2036) |
USD 244.18 Billion |
|
Regional Scope |
|
Dialysis Type (Hemodialysis, Peritoneal Dialysis)
The hemodialysis segment in the dialyzer and dialysis market is the largest and is expected to reach USD 214.2 billion by 2036, rising at a substantial CAGR of 6.10% between 2023 and 2036. In 2022, the segment was worth USD 99.4 billion. The development of new dialysis equipment, rising rates of hypertension, growing demand for home dialysis, and an increase in the prevalence of chronic illnesses (CKD) and end-stage renal disease (ESRD) are some of the major factors. Patients with renal disorders who are elderly are expected to significantly accelerate the segment growth. For instance, three men experience renal failure for every two women. Only 26,309 Americans, or around 1 in 4, were able to receive a kidney transplant in 2022 out of the over 90,000 people waiting for one. The development of new hemodialysis technologies and the rising use of hemodialysis are both driving the expansion of the segment in the market.
End-Users (Hospitals, Home Dialysis)
Dialyzer and dialysis market from the hospitals segment was assessed at USD 73.2 billion in 2023 and is expected to have a value of USD 157.2 billion by 2036, rising at a substantial CAGR of 6.06% over the projected time frame This is because the majority of patients with end-stage renal disease (ESRD) undergo dialysis in a hospital or dialysis facility. Numerous reasons, including the rising incidence of end-stage renal disease (ESRD), the expanding need for superior dialysis services, and the regulatory landscape, are driving the industry. The hospital industry is very concentrated, with a small number of very large companies controlling the majority of the market, including Fresenius Medical Care, Baxter International, and DaVita Healthcare. These businesses are well-known on a global scale and provide a variety of goods and services.
Our in-depth analysis of the global market includes the following segments:
|
Product |
|
|
Dialysis Type |
|
|
End-Users |
|
North American Market Forecast
The dialyzer and dialysis market in North America is projected to be the largest with the largest revenue of USD 87.1 billion by the end of 2036 by growing at a CAGR of 6.10% over the forecast period. Growth in the dialyzer and dialysis solutions market in the area is driven by increasing investments made by major companies in North America. End-stage renal disease (ESRD), affects over 808,000 persons in the US; 31% had a kidney transplant and 69% have dialysis. ESKD is 1.6 times more common in men than in women. For example, a June 2021 Managed Healthcare Executive article stated that the pandemic has significantly increased patient interest in home hemodialysis treatments in North American countries due to worries about COVID-19 spreading throughout the community. Tablo is a compact, portable mobile hemodialyzer that can be used in a variety of healthcare settings, such as clinics, hospitals, and patients' homes. It was developed by US-based medical technology company Outset Medical in June 2023 for the treatment of patients with acute and/or chronic renal failure.
APAC Market Statistics
The Asia Pacific dialyzer and dialysis market is estimated to be the second-largest by developing at a CAGR of 6.31% in the given time frame. The Asia Pacific market is expected to be worth USD 60.8 billion by the end of 2036, up from USD 27.5 billion in 2023. The market is mostly responsible for the rise in infrastructure spending in the healthcare industry, which includes the opening of new dialysis centers and increased access to medical care. For example, in June 2023, the first kidney dialysis center at a government hospital managed by the state was opened by Indian Medical Education Minister Girish Mahajan. Twelve dialysis machines are available at the facility, with two of those units being designated for HIV and AIDS patients.
Author Credits: Radhika Gupta, Shivam Bhutani
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?